Pentoxifylline for Anemia in Chronic Kidney Disease: A Systematic Review and Meta-Analysis
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Pentoxifylline for Anemia in Chronic Kidney Disease: A Systematic Review and Meta-Analysis
Authors
Keywords
Chronic kidney disease, Anemia, Hemoglobin, Ferritin, Meta-analysis, Medical dialysis, Hematocrit, Iron deficiency anemia
Journal
PLoS One
Volume 10, Issue 8, Pages e0134104
Publisher
Public Library of Science (PLoS)
Online
2015-08-04
DOI
10.1371/journal.pone.0134104
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A Randomized, Placebo-Controlled Trial of Pentoxifylline on Erythropoiesis-Stimulating Agent Hyporesponsiveness in Anemic Patients With CKD: The Handling Erythropoietin Resistance With Oxpentifylline (HERO) Trial
- (2015) David W. Johnson et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Pentoxifylline in Heart Failure: A Meta-Analysis of Clinical Trials
- (2014) Sébastien Champion et al. Cardiovascular Therapeutics
- Pentoxifylline does not Alter the Concentration of Hepcidin in Chronic Kidney Disease Patients Undergoing Hemodialysis
- (2014) Sandra A. Antunes et al. INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS
- Prevalence of Anemia in Chronic Kidney Disease in the United States
- (2014) Melissa E. Stauffer et al. PLoS One
- Pentoxifylline for the Treatment of Hemolytic Anemia in a Patient Who Developed Recurrent Gastrointestinal Bleeding While on Continuous-Flow Left Ventricular Assist Device Support
- (2013) Douglas L. Jennings et al. ASAIO JOURNAL
- Anaemia management and mortality risk in chronic kidney disease
- (2013) Walter H. Hörl Nature Reviews Nephrology
- Immune cell dysfunction and inflammation in end-stage renal disease
- (2013) Michiel G. H. Betjes Nature Reviews Nephrology
- Anti-Inflammatory and Anti-Oxidative Nutrition in Hypoalbuminemic Dialysis Patients (AIONID) study: results of the pilot-feasibility, double-blind, randomized, placebo-controlled trial
- (2013) Manoch Rattanasompattikul et al. Journal of Cachexia Sarcopenia and Muscle
- Mechanisms of Anemia in CKD
- (2012) J. L. Babitt et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Pentoxifylline decreases serum levels of tumor necrosis factor alpha, interleukin 6 and C-reactive protein in hemodialysis patients: results of a randomized double-blind, controlled clinical trial
- (2011) L. Gonzalez-Espinoza et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Do pentoxifylline and ascorbic acid improve erythropoiesis stimulating agent resistance?
- (2011) Mira Rho SEMINARS IN DIALYSIS
- An Economic Evaluation of Erythropoiesis-Stimulating Agents in CKD
- (2010) Fiona M. Clement et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Erythropoietic Response and Outcomes in Kidney Disease and Type 2 Diabetes
- (2010) Scott D. Solomon et al. NEW ENGLAND JOURNAL OF MEDICINE
- IMMUNOMODULATORY PROPERTIES OF PENTOXIFYLLINE ARE MEDIATED VIA ADENOSINE-DEPENDENT PATHWAYS
- (2010) Simone Kreth et al. SHOCK
- Effect of Pentoxifylline on GFR Decline in CKD: A Pilot, Double-Blind, Randomized, Placebo-Controlled Trial
- (2009) Robert M. Perkins et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Emerging therapies for chronic kidney disease: what is their role?
- (2009) Eswari Vilayur et al. Nature Reviews Nephrology
- Pentoxifylline improves haemoglobin and interleukin-6 levels in chronic kidney disease
- (2009) PAOLO FERRARI et al. NEPHROLOGY
- Secondary analysis of the CHOIR trial epoetin-α dose and achieved hemoglobin outcomes
- (2008) Lynda A. Szczech et al. KIDNEY INTERNATIONAL
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started